Print this page

Estimated reading time: 3 minutes, 11 seconds

RFID is Being Deployed in the Fight against COVID-19 Featured

RFID is Being Deployed in the Fight against COVID-19 man holding drinking glass

Several countries are trying to come up with different solutions to fight the rising cases of coronavirus pandemic. It is for this reason that technologies are now being combined to counter the impact of the virus. Radio Frequency Identification (RFID) is the latest technology that has made a comeback in many areas, including retail, supply chain, and logistics, as well as in healthcare. Now the technology is being used to fight COVID-19. With the help of microchips that are embedded in RFID tags, the journey of vaccines can now be tracked and authenticated from the manufacturer’s site to the testing site. The same technology can also be used to track personal protective equipment (PPEs), high-value COVID-19 treatment drugs, and antibody testing kits, among others.

Here are other ways in which RFID is used to combat the coronavirus pandemic.

  1. Authentication of testing kits and PPEs

SUKU, a blockchain company, and Smartrack have partnered to develop a technology that will be used to verify and authenticate COVID-19 test kits and PPEs. Their approach takes advantage of near field communication (NFC) RFID tags. The data is fed into the digital identity platform developed by Avery Dennison and integrated into SUKU’s blockchain-based supply chain app. The partnership allows testing kits to be authenticated to ensure that they are legitimate products approved by the FDA. In the age of counterfeit products that have flooded the market, the technology is a step in the right direction which allows counterfeit items to be fought. This helps save lives as coronavirus is a deadly disease that requires quality materials, mainly for front line workers.

  1. Real-time visibility of vaccines

The development of coronavirus vaccines is one of the leading areas of discussions in the world today. As such, many companies are struggling to come up with the best candidate for a vaccine to save lives and stop the ever-increasing infections. With this development, some companies are deploying cutting edge technologies to ensure the vaccine and plasma that is used to treat COVID-19 patients are tracked from source to destination. This is where RFID technology has found work. Biolog-ID announced back in June that it was supplying RFID technology to track convalescent plasma for LifeShare Blood Center. The plasma harvested from recovering coronavirus patients will offer antibodies that will help those suffering from the disease. With blockchain and RFID technologies, vaccines cannot be tampered with, and counterfeit drugs cannot access the supply chain.  

  1. Hospital monitoring

RAIN RFID technology is used in many ways in a hospital setup. While most of these uses are not related directly to the current pandemic, their uses are helping healthcare providers in monitoring resources and ensuring there are high levels of hygiene. For instance, hand-washing hygiene is one of the mechanisms that are recommended by infectious disease specialists as a way of countering the spread of the coronavirus pandemic. RAI RFID allows hospitals to ensure staff complies with the hand-washing protocols and makes it feasible to do so. With an RFID reader situated at a hand-washing station, a tag or a badge on the uniform of a health worker can be read, and management can use the information to track people that have washed their hands when they did so and how.

RFID is also used in hospitals to track the inventory of medical supplies and other high-value assets. It allows administrators to do so without touching the assets or manually counting them. The technology allows staff to quickly locate what they want throughout the facility faster and effectively.

With the immense potential of RFID, it is evident that the fight against the pandemic will rely more on this technology in collaboration with others in the coming days. Governments and medical providers must, therefore, invest in it more if they are to increase their chances of success against the deadly virus.

Read 1349 times
Rate this item
(0 votes)
Scott Koegler

Scott Koegler is Executive Editor for PMG360. He is a technology writer and editor with 20+ years experience delivering high value content to readers and publishers. 

Find his portfolio here and his personal bio here